In conclusion, our results demonstrated that FGFC1 exhibited anti-cancer effects in EGFR-mutant NSCLC PC9 cells in vitro and in vivo via induction of G0/G1 cell cycle arrest and cell apoptosis mediated by the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.